ArticleHaematologica2015
Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation.
Claire Mayeur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it